David Johnson

5.8k total citations · 1 hit paper
24 papers, 533 citations indexed

About

David Johnson is a scholar working on Oncology, General Health Professions and Epidemiology. According to data from OpenAlex, David Johnson has authored 24 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in General Health Professions and 4 papers in Epidemiology. Recurrent topics in David Johnson's work include Cancer Treatment and Pharmacology (3 papers), Head and Neck Cancer Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). David Johnson is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Head and Neck Cancer Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). David Johnson collaborates with scholars based in Hong Kong, China and United States. David Johnson's co-authors include Brigette Ma, Anthony T.�C. Chan, Edwin P. Hui, Kenneth C.W. Wong, W.K. Lam, Lili Li, Ka‐Fai To, Kwok Wai Lo, Qian Tao and Kwan Chee Allen Chan and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

David Johnson

24 papers receiving 523 citations

Hit Papers

Nasopharyngeal carcinoma: an evolving paradigm 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nasopharyngeal carcinoma: an evolving paradigm
    2021 315 citations Kenneth C.W. Wong, Edwin P. Hui et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Johnson Hong Kong 10 198 150 139 119 93 24 533
Xin Qiu Canada 14 194 1.0× 148 1.0× 88 0.6× 101 0.8× 74 0.8× 54 533
Megan Eguchi United States 11 189 1.0× 93 0.6× 76 0.5× 66 0.6× 84 0.9× 37 402
E. Greer Gay United States 7 247 1.2× 109 0.7× 188 1.4× 85 0.7× 322 3.5× 10 680
Emilie A. C. Dronkers Netherlands 13 199 1.0× 47 0.3× 229 1.6× 40 0.3× 97 1.0× 27 552
Pedro De Marchi Brazil 11 277 1.4× 109 0.7× 58 0.4× 115 1.0× 245 2.6× 57 514
Rishi Batra United States 10 88 0.4× 141 0.9× 56 0.4× 62 0.5× 206 2.2× 18 459
Yahua Zhong China 15 296 1.5× 191 1.3× 20 0.1× 122 1.0× 110 1.2× 56 622
Sze Chai Chan Hong Kong 12 131 0.7× 106 0.7× 46 0.3× 39 0.3× 102 1.1× 31 502
Jessica H. Maxwell United States 13 333 1.7× 169 1.1× 510 3.7× 74 0.6× 163 1.8× 38 860
Beela Sarah Mathew India 14 433 2.2× 194 1.3× 78 0.6× 154 1.3× 71 0.8× 27 927

Countries citing papers authored by David Johnson

Since Specialization
Citations

This map shows the geographic impact of David Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Johnson more than expected).

Fields of papers citing papers by David Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Johnson. The network helps show where David Johnson may publish in the future.

Co-authorship network of co-authors of David Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of David Johnson. A scholar is included among the top collaborators of David Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Johnson. David Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loong, Herbert H., Landon L. Chan, Frankie Mo, et al.. (2025). CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation Positive Lung Cancer Beyond Osimertinib Progression. Clinical Lung Cancer. 26(3). e214–e222.e5. 2 indexed citations
2.
Johnson, David, et al.. (2024). Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions. Cancer Treatment Reviews. 125. 102700–102700. 14 indexed citations
3.
Wong, Kenneth C.W., et al.. (2022). Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers. Cancer Treatment Reviews. 105. 102361–102361. 27 indexed citations
4.
Moore, Kelly, Emily B. Schroeder, Glenn K. Goodrich, et al.. (2022). Racial and Ethnic Equity in Care for Hypertension and Diabetes in an Urban Indian Health Organization. Journal of Racial and Ethnic Health Disparities. 10(3). 1319–1328. 1 indexed citations
5.
Johnson, David, et al.. (2022). Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions. Frontiers in Oncology. 12. 970242–970242. 3 indexed citations
6.
Johnson, David, et al.. (2021). Total Neoadjuvant Therapy for High Risk Rectal Cancer in Western and Asian Populations – Current Evidence and Clinical Applications. Clinical Colorectal Cancer. 21(1). 45–54. 4 indexed citations
7.
Johnson, David & Brigette Ma. (2021). Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma. Oral Oncology. 113. 105127–105127. 32 indexed citations
8.
Conigrave, James H., Teagan J. Weatherall, Timothy Dobbins, et al.. (2021). Support can increase use of the AUDIT‐C in Australian Aboriginal Community Controlled Health Services: a cluster randomized trial. Addiction. 116(9). 2304–2315. 12 indexed citations
9.
Wong, Kenneth C.W., Edwin P. Hui, Kwok Wai Lo, et al.. (2021). Nasopharyngeal carcinoma: an evolving paradigm. Nature Reviews Clinical Oncology. 18(11). 679–695. 315 indexed citations breakdown →
10.
11.
Schroeder, Emily B., Kelly Moore, Spero M. Manson, et al.. (2020). A randomized clinical trial of an interactive voice response and text message intervention for individuals with hypertension. Journal of Clinical Hypertension. 22(7). 1228–1238. 19 indexed citations
12.
13.
Dobbins, Timothy, Scott Wilson, Noel Hayman, et al.. (2019). Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trial. BMJ Open. 9(11). e030909–e030909. 14 indexed citations
14.
15.
McFarlane, Catherine, et al.. (2018). Interventions for weight loss in people with chronic kidney disease who are overweight or obese (Intervention Protocol). QUT ePrints (Queensland University of Technology). 1 indexed citations
16.
Emanuel, Ezekiel, Aaron Glickman, & David Johnson. (2017). Measuring the Burden of Health Care Costs on US Families. JAMA. 318(19). 1863–1863. 32 indexed citations
17.
Johnson, David, Robyn McDermott, Peter Clifton, et al.. (2015). Characteristics of Indigenous adults with poorly controlled diabetes in north Queensland: implications for services. BMC Public Health. 15(1). 325–325. 7 indexed citations
18.
Rao, Raj D., Jeffrey A. Sloan, G Wong, et al.. (2006). The efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: A phase III randomized, double blind, placebo-controlled NCCTG trial, N01C3. Journal of Clinical Oncology. 24(18_suppl). 8530–8530. 7 indexed citations
19.
Cree, Marilyn, et al.. (2002). Continuity of Care and Health Decline Associated With a Hip Fracture. Journal of Aging and Health. 14(3). 385–398. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Qiu Breakdown of academic impact, for papers by Megan Eguchi Breakdown of academic impact, for papers by E. Greer Gay Breakdown of academic impact, for papers by Emilie A. C. Dronkers Breakdown of academic impact, for papers by Pedro De Marchi Breakdown of academic impact, for papers by Rishi Batra Breakdown of academic impact, for papers by Yahua Zhong Breakdown of academic impact, for papers by Sze Chai Chan Breakdown of academic impact, for papers by Jessica H. Maxwell Breakdown of academic impact, for papers by Beela Sarah Mathew
Rankless by CCL
2026